Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
20
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Schalop Lee Troy | Director | 5 | $100.0K | $0 | 2026-05-12 |
| KEYSER D JEFFREY | Director | 16 | $250.0K | $0 | 2026-05-12 |
| Chandru Vijay | Director | 10 | $0 | $0 | 2026-01-09 |
| Silberstein David S. | Director, 10% Owner | 10 | $0 | $0 | 2026-01-09 |
| Maccecchini Maria-Luisa | Director | 4 | $0 | $0 | 2026-01-09 |
| Margrave David R. | Chief Financial Officer | 8 | $0 | $0 | 2025-12-18 |
| Bhatia Kishor G. | Chief Scientific Officer | 8 | $0 | $0 | 2025-12-18 |
| BP Directors, LP | 10% Owner | 29 | $0 | $1.08M | 2025-06-13 |
| BIOS Fund II QP, LP | 10% Owner | 5 | $0 | $123.6K | 2025-06-13 |
| Cavu Advisors, LLC | 10% Owner | 36 | $0 | $565.8K | 2025-06-12 |
| BIOS Fund I, LP | 10% Owner | 40 | $0 | $2.00M | 2025-06-12 |
| BIOS Advisors GP, LLC | 10% Owner | 15 | $0 | $168.4K | 2025-05-29 |
| SHARMA PANNA | President and CEO | 5 | $0 | $0 | 2024-07-15 |
| Fletcher Aaron G.L. | 10% Owner | 12 | $0 | $689.1K | 2024-05-24 |
| Bios Equity Partners II, LP | 10% Owner | 9 | $0 | $676.3K | 2024-02-29 |
| Cavu Management, LP | 10% Owner | 7 | $0 | $2.04M | 2023-11-29 |
| BIOS Fund II, LP | 10% Owner | 6 | $0 | $33.5K | 2022-09-02 |
| Kreis Leslie W. | Director, 10% Owner | 12 | $0 | $0 | 2021-11-04 |
| PRENDERGAST FRANKLYN G | Director | 2 | $0 | $0 | 2021-11-04 |
| Health Wildcatters, LLC | 10% Owner | 6 | $0 | $0 | 2020-06-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| KEYSER D JEFFREY | Director | P Buy deriv | 2026-05-12 | 2026-05-14 | 48,544 | — | $0 | 48,544 | SEC↗ |
| Schalop Lee Troy | Director | P Buy deriv | 2026-05-12 | 2026-05-14 | 48,544 | — | $0 | 48,544 | SEC↗ |
| KEYSER D JEFFREY | Director | P Buy | 2026-05-12 | 2026-05-14 | 48,544 | $2.06 | $100.0K | 94,303 | SEC↗ |
| Schalop Lee Troy | Director | P Buy | 2026-05-12 | 2026-05-14 | 48,544 | $2.06 | $100.0K | 48,544 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 17,307 | — | $0 | 17,307 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 28,844 | — | $0 | 28,844 | SEC↗ |
| Maccecchini Maria-Luisa | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 21,152 | — | $0 | 21,152 | SEC↗ |
| Maccecchini Maria-Luisa | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 17,307 | — | $0 | 17,307 | SEC↗ |
| Schalop Lee Troy | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Schalop Lee Troy | Director | A Award deriv | 2026-01-09 | 2026-01-13 | 18,460 | — | $0 | 18,460 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2025-12-18 | 2025-12-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Margrave David R. | Chief Financial Officer | A Award deriv | 2025-12-18 | 2025-12-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Schalop Lee Troy | Director | A Award deriv | 2025-08-19 | 2025-08-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 7,206 | $3.09 | $22.3K | 189,117 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 1,903 | $3.09 | $5.9K | 49,957 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 4,354 | $3.09 | $13.5K | 114,272 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 12,319 | $3.09 | $38.1K | 323,335 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 14,218 | $3.09 | $43.9K | 373,178 | SEC↗ |
| BIOS Fund II QP, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 7,206 | $3.09 | $22.3K | 189,117 | SEC↗ |
| BIOS Fund II QP, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 14,218 | $3.09 | $43.9K | 373,178 | SEC↗ |
| BIOS Fund II QP, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 1,903 | $3.09 | $5.9K | 49,957 | SEC↗ |
| BIOS Fund II QP, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 4,354 | $3.09 | $13.5K | 114,272 | SEC↗ |
| BIOS Fund II QP, LP | 10% Owner | S Sale | 2025-06-13 | 2025-06-13 | 12,319 | $3.09 | $38.1K | 323,335 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 2,886 | $3.38 | $9.8K | 51,860 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 21,557 | $3.38 | $72.9K | 387,396 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 6,601 | $3.38 | $22.3K | 118,626 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 18,678 | $3.38 | $63.1K | 335,654 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 10,925 | $3.38 | $36.9K | 196,323 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 18,678 | $3.38 | $63.1K | 335,654 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 2,886 | $3.38 | $9.8K | 51,860 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 21,557 | $3.38 | $72.9K | 387,396 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 6,601 | $3.38 | $22.3K | 118,626 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-12 | 2025-06-13 | 10,925 | $3.38 | $36.9K | 196,323 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 338 | $3.40 | $1.1K | 408,953 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 103 | $3.40 | $350 | 125,227 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 293 | $3.40 | $996 | 354,332 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 171 | $3.40 | $581 | 207,248 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 45 | $3.40 | $153 | 54,746 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 293 | $3.40 | $996 | 354,332 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 45 | $3.40 | $153 | 54,746 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 338 | $3.40 | $1.1K | 408,953 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 103 | $3.40 | $350 | 125,227 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-11 | 2025-06-13 | 171 | $3.40 | $581 | 207,248 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 409,291 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 2 | $3.40 | $7 | 125,330 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 1 | $3.40 | $3 | 54,791 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 354,625 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 3 | $3.40 | $10 | 207,419 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 409,291 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 2 | $3.40 | $7 | 125,330 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 3 | $3.40 | $10 | 207,419 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 5 | $3.40 | $17 | 354,625 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2025-06-10 | 2025-06-13 | 1 | $3.40 | $3 | 54,791 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 961 | $3.03 | $2.9K | 54,792 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 7,180 | $3.03 | $21.8K | 409,296 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 6,221 | $3.03 | $18.8K | 354,630 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 3,639 | $3.03 | $11.0K | 207,422 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 2,199 | $3.03 | $6.7K | 125,332 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 3,639 | $3.03 | $11.0K | 207,422 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 6,221 | $3.03 | $18.8K | 354,630 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 961 | $3.03 | $2.9K | 54,792 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 7,180 | $3.03 | $21.8K | 409,296 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-29 | 2025-05-29 | 2,199 | $3.03 | $6.7K | 125,332 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 714 | $2.87 | $2.0K | 55,753 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 5,332 | $2.87 | $15.3K | 416,476 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 1,632 | $2.87 | $4.7K | 127,531 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 4,620 | $2.87 | $13.3K | 360,851 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 2,702 | $2.87 | $7.8K | 211,061 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 1,632 | $2.87 | $4.7K | 127,531 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 2,702 | $2.87 | $7.8K | 211,061 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 4,620 | $2.87 | $13.3K | 360,851 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 714 | $2.87 | $2.0K | 55,753 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-28 | 2025-05-29 | 5,332 | $2.87 | $15.3K | 416,476 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 1,000 | $3.05 | $3.0K | 56,467 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 7,478 | $3.05 | $22.8K | 421,808 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 2,290 | $3.05 | $7.0K | 129,163 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 6,479 | $3.05 | $19.8K | 365,471 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 3,790 | $3.05 | $11.6K | 213,763 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 6,479 | $3.05 | $19.8K | 365,471 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 1,000 | $3.05 | $3.0K | 56,467 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 7,478 | $3.05 | $22.8K | 421,808 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 2,290 | $3.05 | $7.0K | 129,163 | SEC↗ |
| BIOS Advisors GP, LLC | 10% Owner | S Sale | 2025-05-27 | 2025-05-29 | 3,790 | $3.05 | $11.6K | 213,763 | SEC↗ |
| KEYSER D JEFFREY | Director | X Exercise deriv | 2024-07-24 | 2024-07-26 | 3,832 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | X Exercise | 2024-07-24 | 2024-07-26 | 3,832 | $3.13 | $12.0K | 0 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SHARMA PANNA | President and CEO | A Award deriv | 2024-07-15 | 2024-07-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Margrave David R. | Chief Financial Officer | A Award deriv | 2024-07-15 | 2024-07-17 | 52,000 | — | $0 | 52,000 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2024-07-15 | 2024-07-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Maccecchini Maria-Luisa | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2024-07-15 | 2024-07-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 1,859 | $6.33 | $11.8K | 57,467 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 13,888 | $6.33 | $87.9K | 429,286 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 4,253 | $6.33 | $26.9K | 131,453 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 1,859 | $6.33 | $11.8K | 57,467 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 13,888 | $6.33 | $87.9K | 429,286 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-24 | 2024-05-28 | 4,253 | $6.33 | $26.9K | 131,453 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 6,944 | $6.25 | $43.4K | 443,174 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 2,126 | $6.25 | $13.3K | 135,706 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 930 | $6.25 | $5.8K | 59,326 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 930 | $6.25 | $5.8K | 59,326 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 6,944 | $6.25 | $43.4K | 443,174 | SEC↗ |
| Cavu Advisors, LLC | 10% Owner | S Sale | 2024-05-23 | 2024-05-28 | 2,126 | $6.25 | $13.3K | 135,706 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 1,832 | $4.87 | $8.9K | 60,256 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 4,185 | $4.87 | $20.4K | 137,832 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 13,686 | $4.87 | $66.7K | 450,118 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 4,185 | $4.87 | $20.4K | 137,832 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 13,686 | $4.87 | $66.7K | 450,118 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-29 | 2024-02-29 | 1,832 | $4.87 | $8.9K | 60,256 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 51,608 | $4.85 | $250.3K | 463,804 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 6,909 | $4.85 | $33.5K | 62,088 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 15,780 | $4.85 | $76.5K | 142,017 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 15,780 | $4.85 | $76.5K | 142,017 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 6,909 | $4.85 | $33.5K | 62,088 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-28 | 2024-02-29 | 51,608 | $4.85 | $250.3K | 463,804 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 4,649 | $4.40 | $20.5K | 68,997 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 10,620 | $4.40 | $46.7K | 157,797 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 34,731 | $4.40 | $152.8K | 515,412 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 34,731 | $4.40 | $152.8K | 515,412 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 4,649 | $4.40 | $20.5K | 68,997 | SEC↗ |
| Bios Equity Partners II, LP | 10% Owner | S Sale | 2024-02-27 | 2024-02-29 | 10,620 | $4.40 | $46.7K | 157,797 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 54,873 | — | $0 | 0 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 16,801 | — | $0 | 0 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 7,347 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 16,801 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 7,347 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise deriv | 2024-01-17 | 2024-01-19 | 54,873 | — | $0 | 0 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 54,873 | $3.13 | $171.8K | 591,036 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 16,801 | $3.13 | $52.6K | 180,938 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 40,893 | $4.20 | $171.8K | 550,143 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 5,475 | $4.20 | $23.0K | 73,646 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 12,521 | $4.20 | $52.6K | 168,417 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 7,347 | $3.13 | $23.0K | 79,121 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 5,475 | $4.20 | $23.0K | 73,646 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 16,801 | $3.13 | $52.6K | 180,938 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 40,893 | $4.20 | $171.8K | 550,143 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 7,347 | $3.13 | $23.0K | 79,121 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | X Exercise | 2024-01-17 | 2024-01-19 | 54,873 | $3.13 | $171.8K | 591,036 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2024-01-17 | 2024-01-19 | 12,521 | $4.20 | $52.6K | 168,417 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2023-11-29 | 2023-12-01 | 91,708 | $3.44 | $315.5K | 371,950 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2023-11-29 | 2023-12-01 | 53,640 | $3.44 | $184.5K | 217,553 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2023-11-29 | 2023-12-01 | 91,708 | $3.44 | $315.5K | 371,950 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | S Sale | 2023-11-29 | 2023-12-01 | 53,640 | $3.44 | $184.5K | 217,553 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 17,748 | $4.40 | $78.1K | 71,774 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 132,575 | $4.40 | $583.3K | 536,163 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 40,586 | $4.40 | $178.6K | 164,137 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 58,711 | $4.40 | $258.3K | 271,193 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 100,380 | $4.40 | $441.7K | 463,658 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 100,380 | $4.40 | $441.7K | 463,658 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 58,711 | $4.40 | $258.3K | 271,193 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 17,748 | $4.40 | $78.1K | 71,774 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 132,575 | $4.40 | $583.3K | 536,163 | SEC↗ |
| Cavu Management, LP | 10% Owner | S Sale | 2022-11-08 | 2022-11-09 | 40,586 | $4.40 | $178.6K | 164,137 | SEC↗ |
| Maccecchini Maria-Luisa | Director | A Award deriv | 2022-10-20 | 2022-10-24 | 3,200 | — | $0 | 3,200 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise deriv | 2022-09-02 | 2022-09-07 | 6,438 | — | $0 | 0 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise deriv | 2022-09-02 | 2022-09-07 | 26,100 | — | $0 | 6,438 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | X Exercise deriv | 2022-09-02 | 2022-09-07 | 6,438 | — | $0 | 0 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | X Exercise deriv | 2022-09-02 | 2022-09-07 | 26,100 | — | $0 | 6,438 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2022-09-02 | 2022-09-07 | 1,275 | $5.20 | $6.6K | 26,093 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise | 2022-09-02 | 2022-09-07 | 6,438 | $1.03 | $6.6K | 27,328 | SEC↗ |
| BP Directors, LP | 10% Owner | S Sale | 2022-09-02 | 2022-09-07 | 5,170 | $5.20 | $26.9K | 20,930 | SEC↗ |
| BP Directors, LP | 10% Owner | X Exercise | 2022-09-02 | 2022-09-07 | 26,100 | $1.03 | $26.9K | 26,100 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | X Exercise | 2022-09-02 | 2022-09-07 | 26,100 | $1.03 | $26.9K | 26,100 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | S Sale | 2022-09-02 | 2022-09-07 | 5,170 | $5.20 | $26.9K | 20,930 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | S Sale | 2022-09-02 | 2022-09-07 | 1,275 | $5.20 | $6.6K | 26,093 | SEC↗ |
| BIOS Fund II, LP | 10% Owner | X Exercise | 2022-09-02 | 2022-09-07 | 6,438 | $1.03 | $6.6K | 27,328 | SEC↗ |
| SHARMA PANNA | President and CEO | A Award deriv | 2022-08-06 | 2022-08-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | X Exercise deriv | 2022-03-17 | 2022-03-21 | 60,432 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | X Exercise deriv | 2022-03-17 | 2022-03-21 | 35,347 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | X Exercise | 2022-03-17 | 2022-03-21 | 60,432 | $189152.16 | $11.43B | 564,038 | SEC↗ |
| Fletcher Aaron G.L. | 10% Owner | X Exercise | 2022-03-17 | 2022-03-21 | 35,347 | $110636.11 | $3.91B | 329,904 | SEC↗ |
| Silberstein David S. | Director | D To issuer deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 0 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 3,200 | SEC↗ |
| KEYSER D JEFFREY | Director | D To issuer deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 3,200 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 3,200 | SEC↗ |
| Chandru Vijay | Director | D To issuer deriv | 2021-11-04 | 2025-09-23 | 3,200 | — | $0 | 0 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | A Award deriv | 2021-11-04 | 2021-11-08 | 3,200 | — | $0 | 3,200 | SEC↗ |
| Margrave David R. | Chief Financial Officer | D To issuer deriv | 2021-10-29 | 2025-09-23 | 26,100 | — | $0 | 0 | SEC↗ |
| Margrave David R. | Chief Financial Officer | A Award deriv | 2021-10-29 | 2025-09-23 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2021-10-29 | 2025-09-23 | 17,400 | — | $0 | 17,400 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | D To issuer deriv | 2021-10-29 | 2025-09-23 | 17,400 | — | $0 | 0 | SEC↗ |
| Margrave David R. | Chief Financial Officer | A Award deriv | 2021-10-29 | 2021-11-02 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2021-10-29 | 2021-11-02 | 17,400 | — | $0 | 17,400 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion deriv | 2020-06-16 | 2020-06-17 | 75,688 | — | $0 | 0 | SEC↗ |
| Silberstein David S. | Director | D To issuer deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 0 | SEC↗ |
| Silberstein David S. | Director | A Award deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Margrave David R. | Chief Financial Officer | A Award deriv | 2020-06-15 | 2025-09-23 | 78,300 | — | $0 | 78,300 | SEC↗ |
| Margrave David R. | Chief Financial Officer | D To issuer deriv | 2020-06-15 | 2025-09-23 | 78,300 | — | $0 | 0 | SEC↗ |
| SHARMA PANNA | President & CEO | A Award deriv | 2020-06-15 | 2025-09-23 | 76,628 | — | $0 | 76,628 | SEC↗ |
| SHARMA PANNA | President & CEO | D To issuer deriv | 2020-06-15 | 2025-09-23 | 76,628 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 9,135 | SEC↗ |
| KEYSER D JEFFREY | Director | D To issuer deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 0 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | D To issuer deriv | 2020-06-15 | 2025-09-23 | 52,200 | — | $0 | 0 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2020-06-15 | 2025-09-23 | 52,200 | — | $0 | 52,200 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Chandru Vijay | Director | D To issuer deriv | 2020-06-15 | 2025-09-23 | 9,135 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | C Conversion deriv | 2020-06-15 | 2020-06-15 | 18,349 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | A Award deriv | 2020-06-15 | 2020-06-15 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Margrave David R. | CFO and Secretary | A Award deriv | 2020-06-15 | 2020-06-15 | 78,300 | — | $0 | 78,300 | SEC↗ |
| Silberstein David S. | Director, 10% Owner | A Award deriv | 2020-06-15 | 2020-06-15 | 9,135 | — | $0 | 9,135 | SEC↗ |
| PRENDERGAST FRANKLYN G | Director | A Award deriv | 2020-06-15 | 2020-06-15 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Bhatia Kishor G. | Chief Scientific Officer | A Award deriv | 2020-06-15 | 2020-06-15 | 52,200 | — | $0 | 52,200 | SEC↗ |
| SHARMA PANNA | CEO & President | A Award deriv | 2020-06-15 | 2020-06-15 | 76,628 | — | $0 | 76,628 | SEC↗ |
| Chandru Vijay | Director | A Award deriv | 2020-06-15 | 2020-06-15 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 80,454 | — | $0 | 0 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 35,181 | — | $0 | 0 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 262,806 | — | $0 | 0 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | A Award deriv | 2020-06-15 | 2020-06-16 | 9,135 | — | $0 | 9,135 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 169,286 | — | $0 | 0 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 289,429 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 35,181 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | J Other deriv | 2020-06-15 | 2020-06-16 | 9,135 | — | $0 | 9,135 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 80,454 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 169,286 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 262,806 | — | $0 | 0 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-16 | 289,429 | — | $0 | 0 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-17 | 168,164 | — | $0 | 0 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion deriv | 2020-06-15 | 2020-06-17 | 23,871 | — | $0 | 0 | SEC↗ |
| KEYSER D JEFFREY | Director | C Conversion | 2020-06-15 | 2020-06-15 | 31,927 | — | $0 | 41,927 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 294,557 | — | $0 | 294,557 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 139,989 | — | $0 | 204,723 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 457,282 | — | $0 | 668,738 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 503,606 | — | $0 | 503,606 | SEC↗ |
| Kreis Leslie W. | Director, 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 61,214 | — | $0 | 89,522 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 139,989 | — | $0 | 204,723 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 457,282 | — | $0 | 668,738 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 61,214 | — | $0 | 89,522 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 294,557 | — | $0 | 294,557 | SEC↗ |
| BIOS Fund I, LP | 10% Owner | C Conversion | 2020-06-15 | 2020-06-16 | 503,606 | — | $0 | 503,606 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion | 2020-06-15 | 2020-06-17 | 41,535 | — | $0 | 211,291 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion | 2020-06-15 | 2020-06-17 | 131,697 | — | $0 | 131,697 | SEC↗ |
| Health Wildcatters, LLC | 10% Owner | C Conversion | 2020-06-15 | 2020-06-17 | 292,605 | — | $0 | 292,605 | SEC↗ |
| KEYSER D JEFFREY | Director | P Buy | 2020-06-11 | 2020-06-15 | 10,000 | $15.00 | $150.0K | 10,000 | SEC↗ |